Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis

被引:8
|
作者
Khurana, Arushi [1 ]
Dalland, Joanna C. [2 ]
Young, Jason R. [3 ]
Inwards, David J. [1 ]
Paludo, Jonas [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN USA
[3] Mayo Clin, Dept Radiol, Div Nucl Med, Rochester, MN USA
关键词
OUTCOMES;
D O I
10.1002/ajh.26233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E298 / E301
页数:4
相关论文
共 50 条
  • [31] Assessment of durable responses after brexucabtagene autoleucel (brexu-cel) in relapsed/refractory mantle cell lymphoma (R/R MCL)
    Pindoria, Lohit
    Munoz, Javier
    Reagan, Patrick
    Goy, Andre
    Miklos, David
    Zheng, Dan
    Fang, Xiang
    Shen, Rhine
    Siddiqi, Rubina
    Kloos, Ioana
    Kersten, Marie Jose
    Wang, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 113 - 114
  • [32] Confirmation of the good real-life effectiveness of brexucabtagene autoleucel in relapsed/refractory mantle cell lymphomas
    Jules, Higue
    HEMATOLOGIE, 2023, 29 (04): : 224 - 225
  • [33] Mantle cell lymphoma in first complete remission
    Laport, Ginna G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (09) : 1118 - 1119
  • [34] Ibrutinib Plus R-ICE Induces Remission in Blastoid Variant Mantle Cell Lymphoma with CNS Relapse
    Oh, Timothy S.
    Burkart, Madelyn
    Behdad, Amir
    Savas, Hatice
    Karmali, Reem
    CASE REPORTS IN HEMATOLOGY, 2022, 2022
  • [35] COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL, CAR-T) FOR THE TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN GREECE
    Loupas, M. A.
    Theodoratou, D.
    Kourlaba, G.
    VALUE IN HEALTH, 2022, 25 (12) : S112 - S112
  • [36] Correlation between Peak Absolute Lymphocyte Count Post Brexucabtagene Autoleucel Infusion and Outcomes in Mantle Cell Lymphoma
    Atallah-Yunes, Albert
    Rees, Matthew James
    Munoz, Javier
    Paludo, Jonas
    Moustafa, Muhamad Alhaj
    Khurana, Arushi
    Bisneto, Jose C. Villasboas
    Rosenthal, Allison C.
    Castro, Januario E.
    Iqbal, Madiha
    Kharfan-Dabaja, Mohamed A.
    Bennani, N. Nora
    Hampel, Paul J.
    Durani, Urshila
    Johnston, Patrick B.
    Corraes, Andre De Menezes Silva
    Porrata, Luis
    Ansell, Stephen M.
    Lin, Yi
    Wang, Yucai
    BLOOD, 2024, 144 : 1651 - 1652
  • [37] Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
    Hess, Georg
    Dreyling, Martin
    Oberic, Lucie
    Gine, Eva
    Zinzani, Pier Luigi
    Linton, Kim
    Vilmar, Adam
    Jerkeman, Mats
    Chen, Jenny M. H.
    Ohler, Anke
    Stilgenbauer, Stephan
    Thieblemont, Catherine
    Lambert, Jonathan
    Zilioli, Vittorio Ruggero
    Sancho, Juan-Manuel
    Jimenez-Ubieto, Ana
    Fischer, Luca
    Eyre, Toby A.
    Keeping, Sam
    Park, Julie E.
    Wu, James J.
    Nunes, Ana
    Reitan, John
    Wade, Sally W.
    Salles, Gilles
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 14 - 25
  • [38] Primary Cutaneous Blastoid Mantle Cell Lymphoma-Case Report
    Estrozi, Bruna
    Sanches, Jose A., Jr.
    Varela, Paulo C. S.
    Bacchi, Carlos E.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2009, 31 (04) : 398 - 400
  • [39] ‘Primary CNS Blastoid Variant of Mantle Cell Lymphoma: A Unique Case’
    Arindam Sarkar
    Mayur Parihar
    Lateef Zameer
    Saurabh Jayant Bhave
    Reena Nair
    Debdeep Dey
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 757 - 759
  • [40] Primary CNS Blastoid Variant of Mantle Cell Lymphoma: A Unique Case
    Sarkar, Arindam
    Parihar, Mayur
    Zameer, Lateef
    Bhave, Saurabh Jayant
    Nair, Reena
    Dey, Debdeep
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (04) : 757 - 759